Fig. 3From: Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humansGenome wide QTL plots of significant modifier loci in (TRAMP x WSB) F2 mice. a Prostate tumor burden. b Seminal vesicle tumor burdenBack to article page